Combined modality therapy for HIV-infected patients with squamous cell carcinoma of the anus: Outcomes and toxicities

Conclusion: For HIV patients with anal carcinoma, CMT yields reasonable local control with significant acute complications. Survival is lower than in the general population, attributable more to the underlying infection than to the malignancy.